September 22, 2017 3:40 AM ET

Life Sciences Tools and Services

Company Overview of Paragon Bioservices, Inc.

Company Overview

Paragon Bioservices, Inc. operates as a contract research and manufacturing organization that focuses on the development and manufacturing of biopharmaceuticals. It engages in the production and purification of therapeutic proteins, monoclonal antibodies, viral vectors, and vaccines-VLPs, as well as production of master and working cell banks. The company provides research services, such as protein expression, antibody services, viruses and VLPs, bacteriophage, vaccines, stem cell services, electron microscopy, and quality systems; good manufacturing practices (GMP) manufacturing, including process development, cell banking services, GMP manufacturing of biopharmaceuticals, GMP virus facilit...

801 West Baltimore Street

UMB BioPark

Building II

Suite 401

Baltimore, MD 21201

United States

Founded in 1990





Key Executives for Paragon Bioservices, Inc.

Chief Executive Officer, President and Director
Age: 57
Founder and Chairman
Senior Vice President of GMP Operations
Vice President of Business Development and Principal Scientist
Senior Vice President of GMP Manufacturing
Compensation as of Fiscal Year 2017.

Paragon Bioservices, Inc. Key Developments

Paragon Bioservices, Inc. Appoints Deborah Wild as Vice President, Quality and Regulatory Affairs

Paragon Bioservices, Inc. announced the appointment of Deborah Wild to the position of Vice President, Quality and Regulatory Affairs, where she will focus on accelerating quality agenda. Ms. Wild is an accomplished Quality Executive/Leader with 30 years' experience. Most recently she ran a thriving consulting practice, for over 14 years, leading Quality Assurance focused initiatives for high profile clients such as Genentech, TEVA, Polynoma, Cytovance, CMC Biologics, etc.

NIAID Awards Paragon Bioservices Multiple Award IDIQ Contract Valued Up to $159 Million for Preclinical Drug Development Services

Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for a variety of National Institute of Allergy and Infectious Diseases (NIAID) medical product development activities. The IDIQ mechanism will allow Paragon to compete within a contractor pool for task order awards up to $159 million. Paragon Bioservicesis one of four awardees to receive the IDIQ valued up to $159 million, with a period of performance of up to 10 years. The award covers the development and introduction of new therapeutic products against a range of critical global infectious diseases. Under the contract, the company will develop manufacturing processes and analytical test methods and perform product characterization.

Paragon Bioservices, Inc. Appoints John Conner as SVP GMP Manufacturing

Paragon Bioservices, Inc. announced the appointment of John Conner to the position of Senior Vice President of GMP Manufacturing. He has over 30 years. He was most recently the Senior Vice President of Operations at the start-up CDMO Cytovance Biologics.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Private Placement
May 8, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Paragon Bioservices, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at